BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6385202)

  • 1. [Correlations between clinical, biochemical and anatomo-pathological findings in orthotopic liver transplants in dogs].
    Bacchella T; Machado MC; da Cunha JE; Gonçalez Y; Behmer OA; Duarte MI
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(2):63-8. PubMed ID: 6385202
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characterization of rejection in orthoptic liver transplants in dogs. II. Hematologic and biochemical findings].
    Bacchella T; Machado MC; Cunha JE; Gonçalez Y
    Rev Paul Med; 1984; 102(3):92-103. PubMed ID: 6382559
    [No Abstract]   [Full Text] [Related]  

  • 3. Signs of early rejection of liver transplant in dogs.
    Olszewski W; Polański J; Sawicki Z; Machowski Z; Rosnowska M
    Pol Med J; 1972; 11(6):1590-5. PubMed ID: 4572846
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biochemical follow-up of the 1st 3 liver transplants performed in Spain].
    Frey González E; Maciá Montserrat M; Orts Costa J
    Med Clin (Barc); 1985 May; 84(17):685-7. PubMed ID: 2861309
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence on the rejection of the canine liver allograft through pregnancy (author's transl)].
    Lie TS; Böhmer F; Nakano H; Ebata H; Möritz B
    Z Immunitatsforsch Exp Klin Immunol; 1974 Apr; 146(5):460-6. PubMed ID: 4282994
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation.
    Shiffman ML; Contos MJ; Luketic VA; Sanyal AJ; Purdum PP; Mills AS; Fisher RA; Posner MP
    Transplantation; 1994 Feb; 57(4):526-32. PubMed ID: 8116036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo perfusion of livers with anti-class II antibody and acute rejection in canine liver transplantation.
    Sakagami K; Saito S; Kurozumi Y; Kobayashi N; Fujiwara T; Matsuno T; Orita K
    Transplant Proc; 1993 Apr; 25(2):1959-61. PubMed ID: 8470243
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characterization of rejection in orthotopic liver transplantation in the dog. III. Anatomo-pathological findings].
    Bacchella T; Machado MC; da Cunha JE; Behmer OA; Duarte MI
    Rev Hosp Clin Fac Med Sao Paulo; 1984; 39(5):215-22. PubMed ID: 6398901
    [No Abstract]   [Full Text] [Related]  

  • 9. A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.
    Monden M; Gotoh M; Kanai T; Valdivia LA; Umeshita K; Endoh W; Nakano Y; Kawai M; Ohzato H; Ukei T
    Transplant Proc; 1990 Feb; 22(1):66-71. PubMed ID: 1689904
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunobiology of hepatic nonparenchymal cells and ex vivo perfusion of the livers with anti-class II antibody: a strategy to prevent hepatic rejection in the dog.
    Sakagami K; Kurozumi Y; Tanakaya K; Saito S; Fujiwara T; Inagaki M; Matsuno T; Takasu S; Higaki K; Toda K
    Transplant Proc; 1995 Feb; 27(1):533-6. PubMed ID: 7879090
    [No Abstract]   [Full Text] [Related]  

  • 11. A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection.
    Neff GW; Montalbano M; Slapak-Green G; Berney T; Bejarano PA; Joshi A; Icardi M; Nery J; Seigo N; Levi D; Weppler D; Pappas P; Ruiz J; Schiff ER; Tzakis AG
    Liver Transpl; 2003 May; 9(5):477-83. PubMed ID: 12740790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation following extracorporeal hypothermia.
    Cree IC; Hayashi T; Bernardez DB
    Can J Surg; 1968 Oct; 11(4):452-63. PubMed ID: 4879063
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine.
    Park KM; Hay JE; Lee SG; Lee YJ; Wiesner RH; Porayko MK; Krom RA
    Transplant Proc; 1996 Jun; 28(3):1738-40. PubMed ID: 8658863
    [No Abstract]   [Full Text] [Related]  

  • 14. Transient hyperphosphatasemia after liver transplantation in infancy.
    Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
    Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired initial function in liver grafts from donors > 50 years of age.
    Buckel E; Sanchez-Urdazpal L; Steers J; Sterioff S; Wiesner R; Krom RA
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1558-9. PubMed ID: 8442188
    [No Abstract]   [Full Text] [Related]  

  • 16. Human liver transplantation without azathioprine.
    Aune S; Schistad G; Skulberg A
    Surg Gynecol Obstet; 1972 Nov; 135(5):727-8. PubMed ID: 4563508
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein-X (LP-X) in liver disease.
    Ritland S; Blomhoff JP; Elgjo K; Gjone E
    Scand J Gastroenterol; 1973; 8(2):155-60. PubMed ID: 4697077
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver function in liver transplantations].
    Lima-Gonçalves E; Machado MC; Bevilacqua RG; Cunha JC; Kieffer J; da Cunha JE; Gonçalez Y; Bacchella T; Srougi M; de Araujo Filho JP
    Rev Hosp Clin Fac Med Sao Paulo; 1969; (4):225-38. PubMed ID: 4898750
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum cholestasis markers as predictors of early outcome after liver transplantation.
    Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
    Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolism in canine liver transplantation with and without immunosuppressive therapy.
    Lie TS; Schmitz H; Nakano H; Ebata H; Bartsch G
    Acta Hepatogastroenterol (Stuttg); 1974 Jun; 21(3):203-12. PubMed ID: 4615550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.